Clarivate Plc Stock Price, News & Analysis
Company Description
Clarivate Plc (NYSE: CLVT) is described as a leading global provider of transformative intelligence. According to the company, it offers enriched data, insights and analytics, workflow solutions and expert services focused on three main areas: Academia & Government, Intellectual Property and Life Sciences & Healthcare. Clarivate is incorporated in Jersey, Channel Islands, and its principal offices referenced in SEC filings are in London, United Kingdom. The company’s shares trade on the New York Stock Exchange under the ticker symbol CLVT.
Clarivate positions its business around helping organizations make better decisions by combining large, curated datasets with domain expertise and software-driven workflows. Its offerings are used by researchers, librarians, universities, government bodies, intellectual property professionals, and life sciences and healthcare companies that need to navigate complex information, regulatory environments and competitive landscapes.
Academia & Government
In the Academia & Government area, Clarivate supports the global research community with data and tools that help assess research impact, discover relevant literature and understand trends. The company highlights the Web of Science platform and related initiatives such as the Web of Science Research Assistant, a generative AI-powered tool that helps researchers find key papers faster, handle complex research tasks and visualize connections using a knowledge graph built on more than 120 years of publication and citation data in the Web of Science Core Collection. Clarivate also publishes analytical outputs such as the Highly Cited Researchers list and the Pulse of the Library report, which draw on Web of Science data and surveys of librarians to provide insight into research performance and library trends.
The Web of Science Research Assistant is described as offering flexible natural-language search in several languages, guided prompts and tasks such as “Understand a topic,” “Literature review” and “Find a journal,” and data visualizations including trend graphs, topic maps and co-citation networks. Clarivate states that this tool is powered by the Clarivate Academic AI Platform and has been developed in collaboration with librarians and researchers worldwide, with a focus on quality, accuracy and privacy. The company also notes the creation of an AI Academic Advisory Council to support responsible advancement of AI in academia.
Intellectual Property
Within Intellectual Property, Clarivate provides data, analytics and workflow software to help organizations manage and protect patents and other IP assets. The company emphasizes solutions such as IPfolio, a cloud-based intellectual property management platform, and Derwent Patent Monitor, an AI-enabled tool for patent review and risk assessment.
IPfolio is described as intellectual property management software (IPMS) that allows customers to manage IP operations across the IP lifecycle from a single workflow platform. Clarivate highlights that IPfolio can support customized workflows, enhance data visibility, and integrate with other data sources via an application programming interface (API). Customers such as Nissan Motor Co., Ltd. and FUJIFILM Holdings Corporation have selected IPfolio to modernize and streamline IP operations, consolidate activities across diverse business segments, and support more efficient, data-driven IP decision-making.
Derwent Patent Monitor is presented as an enterprise solution that streamlines collaborative patent reviews for patentability, freedom to operate, and infringement-related decisions. Built on proprietary data from the Derwent World Patents Index (DWPI), which Clarivate describes as a large database of invention summaries prepared by subject matter experts, Derwent Patent Monitor uses AI to evaluate potential threats and surface critical risks for stakeholders. The software supports structured, project-based reviews and real-time feedback to reduce reliance on scattered communication and help patent teams work more efficiently with R&D partners.
Life Sciences & Healthcare
In Life Sciences & Healthcare, Clarivate uses integrated data assets and AI-powered intelligence to analyze drug pipelines, clinical development and market dynamics. The company publishes the recurring Drugs to Watch report, which identifies therapies expected to deliver significant clinical impact and strong commercial potential over a multi-year horizon. The 2026 edition, for example, highlights therapies in metabolic disease, oncology, immunology, rare conditions and neurological disorders, and draws on ten integrated, AI-enhanced datasets covering the full research and development and commercialization lifecycle.
Clarivate notes that its life sciences analysis relies on resources such as Cortellis Competitive Intelligence, Epidemiology Intelligence, BioWorld, Cortellis Regulatory Intelligence, Cortellis Clinical Trials Intelligence, Cortellis Deals Intelligence and DRG Market Assessment. These tools are used to evaluate therapies in their clinical and commercial context, considering trial results, regulatory status, market conditions and competitive dynamics. Clarivate also produces thematic reports, such as a Companies to Watch report on women’s health innovators, which assesses emerging biotechs based on clinical progress, collaborations, financial strength and intellectual property.
Regulatory intelligence is another focus in this segment. Clarivate has launched the Cortellis Regulatory Intelligence AI Assistant, which uses agentic AI to help life sciences professionals interpret complex regulatory requirements. The assistant can answer regulatory questions in natural language, provide cited and context-aware responses, summarize documents, compare draft and final guidance, and support multilingual use. Clarivate emphasizes that this tool is built on an AI platform informed by more than 30 years of regulatory expertise and is intended to improve accuracy and speed in safety and compliance decision-making.
AI, Data and Workflow Focus
Across its areas of focus, Clarivate repeatedly highlights the combination of enriched data, analytics and workflow software with artificial intelligence. The company describes a technology backbone that enables accelerated and consistent deployment of AI capabilities across its portfolio, including academic research tools, regulatory intelligence and patent analysis. Clarivate states that its AI tools are developed in line with internal AI principles and that it collaborates with customers and advisory groups to align product development with user needs and responsible AI practices.
Clarivate also conducts and publishes research based on surveys and proprietary data to inform its customer communities. The Pulse of the Library report, for example, examines how libraries around the world are approaching AI adoption, open science and budget pressures, and explores links between AI literacy, implementation and confidence among librarians. These publications are positioned as resources that help stakeholders understand evolving environments in research, libraries and healthcare.
Corporate and Financial Reporting
Clarivate files reports with the U.S. Securities and Exchange Commission as a foreign private issuer. Recent Form 8-K filings reference quarterly earnings announcements and supplemental information related to revenue, earnings and guidance. Another filing describes an amendment to the company’s credit agreement that increased total revolving credit commitments and made other changes, illustrating Clarivate’s use of credit facilities as part of its capital structure. Other 8-K filings cover matters such as changes in senior leadership roles and board composition.
According to these filings, Clarivate’s jurisdiction of incorporation is Jersey, Channel Islands, and the company references offices in London, United Kingdom. The filings also confirm that Clarivate is listed under Commission File Number 001-38911 and that it communicates financial results and supplemental information through press releases and its investor relations site.
Role in the Information and Data Processing Sector
Clarivate operates within the broader information and data processing sector, focusing on specialized, domain-specific intelligence rather than general-purpose data hosting. Its activities span data curation, analytics, workflow software and expert services for research, intellectual property and life sciences. By integrating AI with long-standing datasets such as Web of Science and the Derwent World Patents Index, and by publishing analytical reports and rankings, Clarivate positions itself as a source of structured, decision-ready information for institutions that depend on accurate, timely and context-rich data.
Stock Performance
Clarivate Plc (CLVT) stock last traded at $2.49, up 5.62% from the previous close. Over the past 12 months, the stock has lost 38.4%, ranking #1,861 in 52-week price change. At a market capitalization of $1.6B, CLVT is classified as a small-cap stock with approximately 640.7M shares outstanding.
Latest News
Clarivate Plc has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 3 with negative movement. Key topics include AI, earnings, earnings date. View all CLVT news →
SEC Filings
Clarivate Plc has filed 5 recent SEC filings, including 5 Form 4. The most recent filing was submitted on March 17, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all CLVT SEC filings →
Financial Highlights
Clarivate Plc generated $2.5B in revenue over the trailing twelve months, retaining a 66.0% gross margin, operating income reached $71.5M (2.9% operating margin), and net income was -$201.1M, reflecting a -8.2% net profit margin. Diluted earnings per share stood at $-0.30. The company generated $628.5M in operating cash flow. With a current ratio of 0.83, short-term liquidity bears monitoring.
Upcoming Events
Clarivate Nexus early access
Clarivate Plc has 1 upcoming scheduled event. The next event, "Clarivate Nexus early access", is scheduled for July 1, 2026 (in 99 days). Investors can track these dates to stay informed about potential catalysts that may affect the CLVT stock price.
Short Interest History
Short interest in Clarivate Plc (CLVT) currently stands at 50.5 million shares, up 6.7% from the previous reporting period, representing 15.8% of the float. Over the past 12 months, short interest has increased by 18.9%. This moderate level of short interest indicates notable bearish positioning. With 10.1 days to cover, it would take significant time for short sellers to close their positions based on average trading volume.
Days to Cover History
Days to cover for Clarivate Plc (CLVT) currently stands at 10.1 days, up 16.3% from the previous period. This elevated days-to-cover ratio indicates it would take over two weeks of average trading volume for short sellers to exit their positions, suggesting potential for a short squeeze if positive news emerges. The days to cover has increased 33.3% over the past year, indicating either rising short interest or declining trading volume. The ratio has shown significant volatility over the period, ranging from 5.1 to 11.9 days.
CLVT Company Profile & Sector Positioning
Clarivate Plc (CLVT) operates in the Information Technology Services industry within the broader Services-computer Processing & Data Preparation sector and is listed on the NYSE. In monthly performance, the stock ranks #101 among all tracked companies.
Investors comparing CLVT often look at related companies in the same sector, including Concentrix (CNXC), Wns Hldgs (WNS), Dxc Technology (DXC), Globant S A (GLOB), and VNET GROUP INC (VNET). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CLVT's relative position within its industry.